XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss) Amount
Series A Convertible Preferred Stock
Series A-1 Convertible Preferred Stock
Series A-2 Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C-1 and C-2 Convertible Preferred Stock
Series D-1 and D-2 Convertible Preferred Stock
Series E Convertible Preferred Stock
Beginning Balance at Dec. 31, 2020 $ (108,713)   $ 8,173 $ (116,886)                
Convertible preferred stock, Beginning Balance at Dec. 31, 2020           $ 3,368 $ 7,837 $ 5,373 $ 20,806 $ 41,099 $ 49,593  
Convertible preferred stock, Beginning Balance, Shares at Dec. 31, 2020           1,701,141 3,298,732 4,324,998 22,531,819 91,327,903 72,348,452  
Beginning Balance, Shares at Dec. 31, 2020   381,123                    
Issuance of convertible preferred stock                     $ 6,982 $ 80,251
Issuance of convertible preferred stock, Shares                     10,128,771 102,671,041
Stock-based compensation expense 185   185                  
Stock option exercises 265   265                  
Stock option exercises, Shares   54,296                    
Net loss (5,927)     (5,927)                
Ending Balance at Mar. 31, 2021 (114,190)   8,623 (122,813)                
Convertible preferred stock, Ending Balance at Mar. 31, 2021           $ 3,368 $ 7,837 $ 5,373 $ 20,806 $ 41,099 $ 56,575 $ 80,251
Convertible preferred stock, Ending Balance, Shares at Mar. 31, 2021           1,701,141 3,298,732 4,324,998 22,531,819 91,327,903 82,477,223 102,671,041
Ending Balance, Shares at Mar. 31, 2021   435,419                    
Beginning Balance at Dec. 31, 2021 152,315   304,452 (152,137)                
Beginning Balance, Shares at Dec. 31, 2021   29,211,643                    
Stock-based compensation expense 1,594   1,594                  
Stock option exercises 17   17                  
Stock option exercises, Shares   5,593                    
Unrealized loss on marketable securities (5)       $ (5)              
Net loss (12,835)     (12,835)                
Ending Balance at Mar. 31, 2022 $ 141,086   $ 306,063 $ (164,972) $ (5)              
Ending Balance, Shares at Mar. 31, 2022   29,217,236